ACRYCOAT FS30D represents a premium-grade polyacrylate dispersion specifically engineered for advanced pharmaceutical coating applications requiring precise drug delivery mechanism...

ACRYCOAT FS30D represents a premium-grade polyacrylate dispersion specifically engineered for advanced pharmaceutical coating applications requiring precise drug delivery mechanisms. This milky white liquid formulation contains 30% solid content and strictly conforms to European Pharmacopoeia specifications for polyacrylate dispersion 30 percent. Its unique pH-dependent properties create robust films that remain insoluble in gastric fluids (pH below 7) while becoming readily soluble in intestinal environments (pH above 7), making it an ideal choice for targeted drug delivery systems that demand reliable protection for sensitive active ingredients and predictable release profiles in specific gastrointestinal regions.

The pharmaceutical industry extensively utilizes ACRYCOAT FS30D in colon-targeted drug delivery formulations, particularly for medications treating conditions like Crohn's disease, ulcerative colitis, and colorectal cancer where localized therapeutic action is essential. This specialized polymer dispersion serves formulation scientists and pharmaceutical manufacturers developing enteric-coated tablets, delayed-release capsules, and controlled-release dosage forms that must bypass stomach dissolution to achieve optimal therapeutic effects. Its consistent performance ensures drugs reach their intended site of action in the lower gastrointestinal tract without premature metabolic breakdown, thereby maximizing treatment efficacy while minimizing systemic side effects.

Manufacturers choosing ACRYCOAT FS30D gain significant competitive advantages through reliable batch-to-batch consistency, comprehensive regulatory compliance, and formulation flexibility that accelerates product development cycles. This high-quality dispersion delivers exceptional value by reducing development time for new drug formulations while ensuring compliance with international pharmacopoeia standards and manufacturing requirements. The product's proven reliability in commercial-scale manufacturing minimizes production risks and ensures consistent quality in finished pharmaceutical products, making it a trusted choice for companies seeking dependable long-term supply partnerships and predictable performance in critical drug delivery applications.

Key Features:
- Strict conformity to European Pharmacopoeia specifications for polyacrylate dispersion 30 percent
- Precise pH-dependent solubility profile ensuring gastric fluid protection and intestinal release
- High-quality milky white liquid formulation with consistent 30% solid content
- Superior film-forming properties enabling uniform and reliable coating applications
- Guaranteed batch-to-batch consistency with maintained performance characteristics

Benefits:
- Ensures reliable drug protection from gastric acid degradation throughout shelf life
- Enables precise colon-targeted drug delivery for enhanced therapeutic outcomes
- Provides consistent coating performance across different manufacturing scales
- Reduces formulation development time through predictable performance characteristics
- Maintains compliance with international pharmaceutical standards and regulations